Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Depreciation & Amortization - Total (2016 - 2019)

Historic Depreciation & Amortization - Total for Amicus Therapeutics (FOLD) over the last 6 years, with Q1 2019 value amounting to $991000.0.

  • Amicus Therapeutics' Depreciation & Amortization - Total rose 227.04% to $991000.0 in Q1 2019 from the same period last year, while for Dec 2019 it was $991000.0, marking a year-over-year decrease of 7640.48%. This contributed to the annual value of $5.0 million for FY2024, which is 416.67% up from last year.
  • Per Amicus Therapeutics' latest filing, its Depreciation & Amortization - Total stood at $991000.0 for Q1 2019, which was up 227.04% from $1.2 million recorded in Q4 2018.
  • Amicus Therapeutics' 5-year Depreciation & Amortization - Total high stood at $1.2 million for Q4 2018, and its period low was $353000.0 during Q2 2015.
  • For the 5-year period, Amicus Therapeutics' Depreciation & Amortization - Total averaged around $830562.5, with its median value being $873500.0 (2016).
  • In the last 5 years, Amicus Therapeutics' Depreciation & Amortization - Total tumbled by 1085.86% in 2015 and then skyrocketed by 12683.54% in 2016.
  • Amicus Therapeutics' Depreciation & Amortization - Total (Quarter) stood at $395000.0 in 2015, then skyrocketed by 129.37% to $906000.0 in 2016, then grew by 22.96% to $1.1 million in 2017, then increased by 6.37% to $1.2 million in 2018, then fell by 16.37% to $991000.0 in 2019.
  • Its Depreciation & Amortization - Total stands at $991000.0 for Q1 2019, versus $1.2 million for Q4 2018 and $1.1 million for Q3 2018.